ID   WAe009-A-6
SY   H9 shDLL4; H9 DLL4
DR   hPSCreg; WAe009-A-6
DR   Wikidata; Q54993569
RX   PubMed=27346199;
RX   PubMed=29246573;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Knockout cell: Method=shRNA knockdown; HGNC; 2910; DLL4.
ST   Source(s): PubMed=27346199
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 12-03-20; Version: 5
RX   PubMed=27346199; DOI=10.1016/j.scr.2016.04.005;
RA   Gonzalez-Pozas F., Montes R., Lopez-Onieva L., Romero T.,
RA   Domingo-Reines J., Real P.J., Ramos-Mejia V., Ayllon V.;
RT   "Generation of human pluripotent stem cell lines with suppressed
RT   expression of the Notch ligand DLL4 using short hairpin RNAs.";
RL   Stem Cell Res. 16:735-739(2016).
RX   PubMed=29246573; DOI=10.1016/j.scr.2017.07.008;
RA   Gonzalez-Pozas F., Montes R., Domingo-Reines J., Ayllon V.,
RA   Ramos-Mejia V.;
RT   "Establishment of 2 control and 2 hPSC cell lines constitutively
RT   expressing the Notch ligand DLL4.";
RL   Stem Cell Res. 25:274-277(2017).